Institute of Cancer and Genomic Sciences

We make a powerful contribution to understanding how genetic abnormalities within cancer cells lead to disease. Through Birmingham’s Cancer Research UK Clinical Trials Unit- one of Europe’s leading clinical trials unit- we use this information to design and rigorously assess new and proven cancer treatments. In so doing, we will play a significant role in accelerating the ultimate control of cancer.

Also in 'Institute of Cancer and Genomics'

Latest videos

Life Sciences in Six - Dr Joanna Parish

My story: Graham Silk

Precision Medicine: Diagnostic medical genetics

Dr Andrew Peet - Support our brain cancer in children research

Latest news

Posted 21 August 2017

Supporting innovation in research into cancer surgery

Professor Dion Morton, Director of the Experimental Cancer Medicine Centre at the University of Birmingham, writes for the NIHR Blog on how the NIHR health research system has supported innovative research in his area of cancer surgery.

Posted 26 June 2017

Research finds cancer hijacks natural cell process to survive

Cancer tumours manipulate a natural cell process to promote their survival suggesting that controlling this mechanism could stop progression of the disease, according to new research by the Universities of Birmingham and Oxford.

View all news